Neurodegenerative focus The Roskamp Institute specializes in neuropsychiatric and neurodegenerative disorders with a strong emphasis on Alzheimer's disease, indicating opportunities to position high-value research collaborations, clinical trial partnerships, and grant-enabled study programs with pharmaceutical and biotech clients.

Research funding Recent funding includes a $43K programmatic grant for neurodegenerative research, suggesting potential for co-funding partnerships, grant-writing services, and sponsored research opportunities with foundations, universities, and government programs.

Expansion and programs New initiatives such as the Brain Reserve Index user experience program and partnerships to support dementia caregivers show a growth trajectory and productized offerings that can be bundled with analytics, digital health tools, and caregiver support platforms for industry clients.

Education and outreach Active collaborations with USF, Mote Marine Laboratory, Save Its Seabirds, and Southeast High School indicate strong community engagement and potential for industry-led STEM education programs, internships, and sponsored research opportunities that could be monetized as corporate social responsibility initiatives.

Financial stature With reported revenue in the $25M–$50M range and several high-profile research initiatives, the institute presents as a mid-to-upper mid-market partner for contract research, advisory services, and technology licensing discussions aligned with pharma and biotech buyers.